跳至主要内容
临床试验/NL-OMON45341
NL-OMON45341已完成4 期

Standard Topical Ointment or Doxepin against pruritus in burn patients - 2-STOP trial

Vereniging Samenwerkende Brandwondencentra Nederland0 个研究点目标入组 27 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
27

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • * Age * 18 years
  • * Healed burns
  • * Itch with an intensity * 3 as determined by the VAS score for itch at time of the enrolment
  • * Treatment in one of the three Dutch burn centres
  • * Total area that itches must not exceed >10% TBSA

排除标准

  • * Unable to give informed consent
  • * Unable to understand and fill in VAS scores and questionnaires (as determined by the treating burn physician)
  • * Cutaneous or systemic disease causing itch
  • * Any diseases or condition that is associated with adverse effects using Doxepin, that is:
  • o Contra-indications:
  • * Hypersensitivity to any of its components
  • o Precautions:
  • * Glaucoma
  • * A tendency to urinary retention
  • * Sever liver disease
  • * Sever heart disease (including cardiac arrhythmias)
  • * Pregnancy and lactation

研究者

发起方
Vereniging Samenwerkende Brandwondencentra Nederland

相似试验

Standard Topical Ointment or Doxepin against... | 临床试验